id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-6526-0017,FDA,FDA-2017-D-6526,Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier Guidance for Industry,Other,Guidance,2018-09-20T04:00:00Z,2018,9,2018-09-20T04:00:00Z,,2024-11-07T01:37:43Z,,1,0,0900006483737381
FDA-2017-D-6526-0016,FDA,FDA-2017-D-6526,"Grandfathering Policy for Packages and Homogenous Cases of Product
Without a Product Identifier; Guidance for Industry; Availability",Notice,Notice of Availability,2018-09-20T04:00:00Z,2018,9,2018-09-20T04:00:00Z,,2018-09-20T14:08:17Z,2018-20503,0,0,0900006483735b67
FDA-2017-D-6526-0001,FDA,FDA-2017-D-6526,Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2017-11-27T05:00:00Z,2017,11,2017-11-27T05:00:00Z,2018-01-27T04:59:59Z,2018-01-27T02:01:47Z,2017-25457,0,0,0900006482cae5c8
FDA-2017-D-6526-0002,FDA,FDA-2017-D-6526,Draft Guidance for Industry Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier,Other,Guidance,2017-11-27T05:00:00Z,2017,11,2017-11-27T05:00:00Z,,2019-08-21T18:23:13Z,,0,0,0900006482cafc82